Effects of Single-Capsule 17β-Estradiol/Progesterone (TX-001HR) on Weight and Blood Pressure in Postmenopausal Women of the REPLENISH Trial Read more about Effects of Single-Capsule 17β-Estradiol/Progesterone (TX-001HR) on Weight and Blood Pressure in Postmenopausal Women of the REPLENISH Trial
Correlations of Serum Estradiol and Estrone Concentrations with Menopausal Outcomes and Bleeding Read more about Correlations of Serum Estradiol and Estrone Concentrations with Menopausal Outcomes and Bleeding
TX-001HR is Associated with a Clinically Meaningful Effect on Severity of Moderate to Severe Vasomotor Symptoms in the REPLENISHTrial Read more about TX-001HR is Associated with a Clinically Meaningful Effect on Severity of Moderate to Severe Vasomotor Symptoms in the REPLENISHTrial
17β-Estradiol/Progesterone in a Single, Oral, Softgel Capsule (TX-001HR) Significantly Increased the Number of VMS Symptom-free Days in the REPLENISH Trial Read more about 17β-Estradiol/Progesterone in a Single, Oral, Softgel Capsule (TX-001HR) Significantly Increased the Number of VMS Symptom-free Days in the REPLENISH Trial
Effects of Single-Capsule 17β-Estradiol/Progesterone (TX-001HR) on Metabolic Parameters and Cardiovascular Outcomes in Menopausal Women of the REPLENISH Trial Read more about Effects of Single-Capsule 17β-Estradiol/Progesterone (TX-001HR) on Metabolic Parameters and Cardiovascular Outcomes in Menopausal Women of the REPLENISH Trial
